Literature DB >> 9367410

Recombinant proteinase 3 (Wegener's antigen) expressed in Pichia pastoris is functionally active and is recognized by patient sera.

M C Harmsen1, P Heeringa, Y M van der Geld, M G Huitema, A Klimp, A Tiran, C G Kallenberg.   

Abstract

The open reading frame of human proteinase 3 (PR3) without the prepro-peptide was cloned and expressed in Escherichia coli (rcPR3) and in Pichia pastoris (rpPR3). The 6-histidine tagged rpPR3 was efficiently secreted into culture supernatant from which it could be purified by immobilized metal chelate chromatography. Purified rpPR3 migrated as a single 32-kD band on SDS-PAGE and harboured protease activity that could be inhibited with inhibitors specific for serine-proteases. By indirect antigen-capture ELISA using rpPR3, 60% of sera from patients with Wegener's granulomatosis bound to the recombinant product, although it was not recognized in ELISA with directly coated rpPR3.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367410      PMCID: PMC2265502          DOI: 10.1111/j.1365-2249.1997.tb08325.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

1.  Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3.

Authors:  P Bini; J E Gabay; A Teitel; M Melchior; J L Zhou; K B Elkon
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

Review 2.  Emerging applications of the methylotrophic yeasts.

Authors:  G H Wegner
Journal:  FEMS Microbiol Rev       Date:  1990-12       Impact factor: 16.408

3.  Cleavage and inactivation of human C1 inhibitor by the human leukocyte proteinase, proteinase 3.

Authors:  R W Leid; B E Ballieux; I van der Heijden; C Kleyburg-van der Keur; E C Hagen; L A van Es; F J van der Woude; M R Daha
Journal:  Eur J Immunol       Date:  1993-11       Impact factor: 5.532

4.  Structure, chromosomal assignment, and expression of the gene for proteinase-3. The Wegener's granulomatosis autoantigen.

Authors:  A B Sturrock; K F Franklin; G Rao; B C Marshall; M B Rebentisch; R S Lemons; J R Hoidal
Journal:  J Biol Chem       Date:  1992-10-15       Impact factor: 5.157

5.  Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity.

Authors:  B A van de Wiel; K M Dolman; C H van der Meer-Gerritsen; C E Hack; A E von dem Borne; R Goldschmeding
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

Review 6.  Recent advances in the expression of foreign genes in Pichia pastoris.

Authors:  J M Cregg; T S Vedvick; W C Raschke
Journal:  Biotechnology (N Y)       Date:  1993-08

7.  Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis.

Authors:  K M Dolman; C A Stegeman; B A van de Wiel; C E Hack; A E von dem Borne; C G Kallenberg; R Goldschmeding
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

8.  High-level production of spinach glycolate oxidase in the methylotrophic yeast Pichia pastoris: engineering a biocatalyst.

Authors:  M S Payne; K L Petrillo; J E Gavagan; L W Wagner; R DiCosimo; D L Anton
Journal:  Gene       Date:  1995-12-29       Impact factor: 3.688

Review 9.  Yeast systems for the commercial production of heterologous proteins.

Authors:  R G Buckholz; M A Gleeson
Journal:  Biotechnology (N Y)       Date:  1991-11

10.  Characterization of a recombinant proteinase 3, the autoantigen in Wegener's granulomatosis and its reactivity with anti-neutrophil cytoplasmic autoantibodies.

Authors:  V Witko-Sarsat; L Halbwachs-Mecarelli; R P Almeida; P Nusbaum; M Melchior; G Jamaleddine; P Lesavre; B Descamps-Latscha; J E Gabay
Journal:  FEBS Lett       Date:  1996-03-11       Impact factor: 4.124

View more
  7 in total

1.  Anti-PR3 immune responses induce segmental and necrotizing glomerulonephritis.

Authors:  V C Primo; S Marusic; C C Franklin; W H Goldmann; C G Achaval; R N Smith; M A Arnaout; B Nikolic
Journal:  Clin Exp Immunol       Date:  2009-12-14       Impact factor: 4.330

2.  A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptide.

Authors:  J Sun; D N Fass; M A Viss; A M Hummel; H Tang; H A Homburger; U Specks
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

Review 3.  B cell epitope specificity in ANCA-associated vasculitis: does it matter?

Authors:  Y M van der Geld; C A Stegeman; C G M Kallenberg
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

4.  Epitope mapping of anti-PR3 antibodies using chimeric human/mouse PR3 recombinant proteins.

Authors:  D Selga; M Segelmark; J Wieslander; L Gunnarsson; T Hellmark
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

Review 5.  Recombinant protein expression in Pichia pastoris.

Authors:  J M Cregg; J L Cereghino; J Shi; D R Higgins
Journal:  Mol Biotechnol       Date:  2000-09       Impact factor: 2.860

Review 6.  What you should know about PR3-ANCA. Structural aspects of antibodies to proteinase 3 (PR3).

Authors:  E Peen; R C Williams
Journal:  Arthritis Res       Date:  2000-06-12

Review 7.  What you should know about PR3-ANCA. Conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCA.

Authors:  U Specks
Journal:  Arthritis Res       Date:  2000-06-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.